MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 148 filers reported holding MIRUM PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.16 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $25,950,826 | +47.6% | 759,018 | +8.4% | 0.00% | +33.3% |
Q1 2024 | $17,586,914 | +30.6% | 700,116 | +53.4% | 0.00% | +50.0% |
Q4 2023 | $13,470,507 | +77.0% | 456,318 | +89.5% | 0.00% | 0.0% |
Q3 2023 | $7,608,522 | +7.0% | 240,776 | -12.4% | 0.00% | 0.0% |
Q2 2023 | $7,111,560 | -24.5% | 274,896 | -29.9% | 0.00% | 0.0% |
Q1 2023 | $9,424,776 | +9.4% | 392,372 | -11.2% | 0.00% | 0.0% |
Q4 2022 | $8,614,613 | +173616.7% | 441,775 | +87.2% | 0.00% | +100.0% |
Q3 2022 | $4,959 | +109.2% | 236,028 | +93.8% | 0.00% | 0.0% |
Q2 2022 | $2,370 | -99.6% | 121,808 | +323.9% | 0.00% | – |
Q1 2022 | $633,000 | -3.8% | 28,737 | -30.4% | 0.00% | – |
Q4 2021 | $658,000 | +48.9% | 41,273 | +80.1% | 0.00% | – |
Q3 2020 | $442,000 | -26.6% | 22,919 | -25.9% | 0.00% | – |
Q2 2020 | $602,000 | +12.7% | 30,940 | -18.8% | 0.00% | – |
Q1 2020 | $534,000 | +381.1% | 38,117 | +244.5% | 0.00% | – |
Q3 2019 | $111,000 | – | 11,066 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Frazier Life Sciences Management, L.P. | 6,470,392 | $204,464,387 | 13.58% |
NEA Management Company, LLC | 2,186,243 | $69,085,279 | 5.34% |
TANG CAPITAL MANAGEMENT LLC | 1,137,107 | $35,932,581 | 5.07% |
BOONE CAPITAL MANAGEMENT LLC | 389,791 | $12,317,396 | 3.89% |
Highlander Partners, L.P. | 122,980 | $3,886,168 | 3.84% |
BVF INC/IL | 4,370,024 | $138,092,758 | 3.72% |
Prosight Management, LP | 353,508 | $11,170,853 | 3.54% |
Novo Holdings A/S | 1,500,000 | $47,400,000 | 3.50% |
Nicholas Investment Partners, LP | 1,199,366 | $37,899,966 | 2.83% |
Eventide Asset Management | 3,958,579 | $125,091,097 | 2.25% |